Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02982928 · ClinicalTrials.gov registry record

Tylenol Levels in Bariatric Patients

A clinical trial, sponsored by Nationwide Children's Hospital.

Completed
Registry status
11
Enrollment target

NCT02982928: Completed study, sponsored by Nationwide Children's Hospital.

NCT02982928 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02982928 has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

The current study is designed to measure and evaluate the pharmacokinetic profiling of acetaminophen in the young obese patient population.

Primary Outcome

To determine whether adequate serum concentration of acetaminophen is achieved.

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2017-03-06
Est. Completion 2018-01-22
Nationwide Children's Hospital

188 total trials

What the finished NCT02982928 record still lists

NCT02982928 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02982928 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02982928 about?

NCT02982928 is a clinical study titled "Tylenol Levels in Bariatric Patients". The current study is designed to measure and evaluate the pharmacokinetic profiling of acetaminophen in the young obese patient population.

What is the current status of trial NCT02982928?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2017-03-06. Estimated completion is 2018-01-22.

Who is sponsoring clinical trial NCT02982928?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02982928, the US trial registry maintained by the National Library of Medicine. NCT02982928 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.